BACKGROUND: Most cardiac surgery patients undergo median sternotomy during open heart surgery. Sternotomy healing is an arduous, very complex, and multifactorial process dependent on many independent factors affecting the sternum and the surrounding soft tissues. Complication rates for median sternotomy range from 0.5 to 5%; however, mortality rates from complications are very variable at 7-80%. Low calcidiol concentration below 80 nmol/L results in calcium absorptive impairment and carries a risk of bone loss, which is considered as a risk factor in the sternotomy healing process. The primary objective of this clinical trial is to compare the incidence of all postoperative sternotomy healing complications in two parallel patient groups administered cholecalciferol or placebo. The secondary objectives are focused on general patient recovery process: sternal bone healing grade at the end of the trial, length of hospitalization, number of days spent in the ICU, number of days spent on mechanical lung ventilation, and number of hospital readmissions for sternotomy complications. METHODS: This clinical trial is conducted as monocentric, randomized, double-blind, placebo-controlled, with planned enrollment of 600 patients over 4 years, approximately 300 in the placebo arm and 300 in the treatment arm. Males and females from 18 to 95 years of age who fulfill the indication criteria for undergoing cardiac surgery with median sternotomy can be included in this clinical trial, if they meet the eligibility criteria. DISCUSSION: REINFORCE-D is the first monocentric trial dividing patients into groups based on serum calcidiol levels, and with dosing based on serum calcidiol levels. This trial may help to open up a wider range of postoperative healing issues. TRIAL REGISTRATION: EU Clinical Trials Register, EUDRA CT No: 2016-002606-39 . Registered on September 8, 2016.

Department of Cardiac Surgery Na Homolce Hospital Prague Czech Republic

Department of Clinical Biochemistry Hematology and Immunology Na Homolce Hospital Prague Czech Republic

Department of Clinical Pharmacy Na Homolce Hospital Prague Czech Republic

Department of Medical Physics Na Homolce Hospital Prague Czech Republic

Department of Pharmacology 2nd Faculty of Medicine Charles University Prague Czech Republic

Department of Radiology Na Homolce Hospital Prague Czech Republic

Hospital Pharmacy Na Homolce Hospital Prague Czech Republic

Institute of Pharmacology 1st Faculty of Medicine Charles University Prague Czech Republic

Zobrazit více v PubMed

Boskey AL, et al. Mineralization in mammals. In: Feldman D, et al., editors. Vitamin D. London: Elsevier Books; 2018. p. 391.

Holick MF. Vitamin D: extraskeletal health. Endocrinol Metab Clin N Am. 2010;39:381–400. doi: 10.1016/j.ecl.2010.02.016. PubMed DOI

Giustina A, Adler RA, Binkley N, et al. Consensus statement from 2nd International Conference on Controversies in Vitamin D. Rev Endocr Metab Disord. 2020;21(1):89–116. doi: 10.1007/s11154-019-09532-w. PubMed DOI PMC

Holick MF. Optimal vitamin D status for the prevention and treatment of osteoporosis. Drugs Aging. 2007;24(12):1017–1029. doi: 10.2165/00002512-200724120-00005. PubMed DOI

Heaney RP, Dowell MS, Hale CA, Bendich A. Calcium absorption varies within the reference range for serum 25-hydroxyvitamin D. J Am Coll Nutr. 2003;22(2):142–146. doi: 10.1080/07315724.2003.10719287. PubMed DOI

Wang TJ, Pencina MJ, Booth SL, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation. 2008;117:503–511. doi: 10.1161/CIRCULATIONAHA.107.706127. PubMed DOI PMC

Somjen D, Weisman Y, Kohen F, Gayer B, Limor R, Sharon O, Jaccard N, Knoll E, Stern N. 25-Hydroxyvitamin D3-1α-hydroxylase is expressed in human vascular smooth muscle cells and is upregulated by parathyroid hormone and estrogenic compounds. Circulation. 2005;111:1666–1671. doi: 10.1161/01.CIR.0000160353.27927.70. PubMed DOI

Geen JJ, Robinson DA, Wilson GE, et al. Calcitriol modulation of cardiac contractile performance via protein kinase C. J Mol Cell Cariol. 2006;41:350–359. doi: 10.1016/j.yjmcc.2006.05.019. PubMed DOI

Motiwala SR, Wang T. Vitamin D and cardiovascular disease. Curr Opin Nephrol Hypertens. 2011;20:345–353. doi: 10.1097/MNH.0b013e3283474985. PubMed DOI

Tomson J, Embrson J, Hill J, et al. Vitamin D and risk of death from vascular and non-vascular causes in the Whitehall study and meta-analyses of 12 000 deaths. Eur Heart J. 2013;34:1365–1374. doi: 10.1093/eurheartj/ehs426. PubMed DOI

Zittermann A, et al. Vitamin D status and the risk of major adverse cardiac and cerebrovascular events in cardiac surgery. Eur Heart J. 2013;34:1358–1364. doi: 10.1093/eurheartj/ehs468. PubMed DOI

Koester MC, Spindler KP. Pharmacologic agents in fracture healing. Clin Sports Med. 2006;25(1):63–73. doi: 10.1016/j.csm.2005.08.004. PubMed DOI

Eschle D, Aeschlimann AG. Is supplementation of vitamin d beneficial for fracture healing? A short review of the literature. Geriatr Orthop Surg Rehabil. 2011;2(3):90–93. doi: 10.1177/2151458511408568. PubMed DOI PMC

Burkiewicz CJ, et al. Vitamin D and skin repair: a prospective, double-blind and placebo controlled study in the healing of leg ulcers. Rev Col Bras Cir. 2012;39(5):401–407. doi: 10.1590/S0100-69912012000500011. PubMed DOI

Li AE. Evaluation of complications after sternotomy using single- and multidetector CT with three-dimensional volume rendering. Am J Roentgenol. 2003;181:1065–1070. doi: 10.2214/ajr.181.4.1811065. PubMed DOI

Ridderstolpe L, Gill H, Granfeldt H, Ahlfeldt H, Rutberg H. Superficial and deep sternal wound complications: incidence, risk factors and mortality. Eur J Cardiothorac Surg. 2001;20:1168–1175. doi: 10.1016/S1010-7940(01)00991-5. PubMed DOI

Schimmer C, Reents W, Berneder S, Eigel P, Sezer O, Scheld H, et al. Prevention of sternal dehiscence and infection in high-risk patients: a prospective randomized multicenter trial. Ann Thorac Surg. 2008;86:1897–1904. doi: 10.1016/j.athoracsur.2008.08.071. PubMed DOI

Baillot R, Cloutier D, Montalin L, Cote L, Lellouche F, Houde C, et al. Impact of deep sternal wound infection management with vacuum-assisted closure therapy followed by sternal osteosynthesis: a 15-year review of 23,499 sternotomies. Eur J Cardiothorac Surg. 2010;37:880–887. doi: 10.1016/j.ejcts.2009.09.023. PubMed DOI

Heilmann C, Stahl R, Schneider C, et al. Wound complications after median sternotomy: a single-centre study. Interact Cardiovasc Thorac Surg. 2013;16(5):643–648. doi: 10.1093/icvts/ivs554. PubMed DOI PMC

Stacy GS, et al. Evaluation of sternal bone healing with computed tomography and a quantitative scoring algorithm. Open Med Imaging J. 2014;8(1):29–35. doi: 10.2174/1874347101408010029. DOI

Armas LA, Hollis BW, Heaney RP. Vitamin D2 is much less effective than vitamin D3 in humans. J Clin Endocrinol Metab. 2004;89:5387–5391. doi: 10.1210/jc.2004-0360. PubMed DOI

Kennel KA, Drake MT, Hurley DL. Vitamin D deficiency in adults: when to test and how to treat. Mayo Clin Proc. 2010;85:752–757. doi: 10.4065/mcp.2010.0138. PubMed DOI PMC

Nanesen H, Samson MM, Verhaar HJJ. Vitamin D deficiency, muscle function, and falls in elderly people. Am J Clin Nutr. 2002;75:611–615. doi: 10.1093/ajcn/75.4.611. PubMed DOI

Ettehad H. Changes in the serum level of vitamin D during healing of tibial and femoral shaft fractures. Trauma Mon. 2014;19(1):e10946. doi: 10.5812/traumamon.10946. PubMed DOI PMC

Marmor M. Osteoporotic fracture care: are we closer to gold standards? J Orthop Trauma. 2015;12:53–56. doi: 10.1097/BOT.0000000000000469. PubMed DOI

Institute of Medicine (US) Committee to Review Dietary Reference Intakes for Vitamin D and Calcium et al. In: Dietary reference intakes for calcium and vitamin D. Ross AC, Taylor CL, Yaktine AL, et al., editors. Washington (DC): National Academies Press (US); 2011. PubMed

Merck KGaA . Vigantol 0,5MG/ML POR GTT SOL 10ML SmPC. 2014.

Bolland MJ, et al. Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women’s Health Initiative limited access dataset and meta-analysis. BMJ. 2011;342:d2040. doi: 10.1136/bmj.d2040. PubMed DOI PMC

Sato Y, Honda Y, Kuno H, Oizumi K. Menatetrenone ameliorates osteopenia in disuse-affected limbs of vitamin D- and K-deficient stroke patients. Bone. 1998;23(3):291–296. doi: 10.1016/S8756-3282(98)00108-2. PubMed DOI

Iwamoto I, Kosha S, Noguchi S, et al. A longitudinal study of the effect of vitamin K2 on bone mineral density in postmenopausal women a comparative study with vitamin D3 and estrogen-progestin therapy. Maturitas. 1999;31(2):161–164. doi: 10.1016/S0378-5122(98)00114-5. PubMed DOI

Zittermann A, et al. Vitamin D supplementation, body weight and human serum 25-hydroxyvitamin D response: a systematic review. Eur J Nutr. 2014;53:367–374. doi: 10.1007/s00394-013-0634-3. PubMed DOI

Kearns MD. Large, single-dose, oral vitamin d supplementation in adult populations: a systematic review. Endocr Pract. 2014;20(4):341–351. doi: 10.4158/EP13265.RA. PubMed DOI PMC

Wolpowitz D, Gilchrest BA. The vitamin D questions: how much do you need and how should you get it? J Am Acad Dermatol. 2006;54(2):301–317. doi: 10.1016/j.jaad.2005.11.1057. PubMed DOI

Leventis P, Kiely PD. The tolerability and biochemical effects of high-dose bolus vitamin D2 and D3 supplementation in patients with vitamin D insufficiency. Scand J Rheumatol. 2009;38(2):149–153. doi: 10.1080/03009740802419081. PubMed DOI

Haines ST, et al. Vitamin D supplementation: what’s known, what to do, and what’s needed. Pharmacotherapy. 2012;32(4):354–382. doi: 10.1002/phar.1037. PubMed DOI